1.48
price up icon3.50%   0.05
after-market Handel nachbörslich: 1.44 -0.04 -2.70%
loading
Schlusskurs vom Vortag:
$1.43
Offen:
$1.43
24-Stunden-Volumen:
991.45K
Relative Volume:
0.94
Marktkapitalisierung:
$419.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-125.04M
KGV:
-1.8049
EPS:
-0.82
Netto-Cashflow:
$-122.99M
1W Leistung:
-5.73%
1M Leistung:
+5.71%
6M Leistung:
+12.12%
1J Leistung:
-46.95%
1-Tages-Spanne:
Value
$1.405
$1.485
1-Wochen-Bereich:
Value
$1.3301
$1.66
52-Wochen-Spanne:
Value
$1.01
$3.305

Erasca Inc Stock (ERAS) Company Profile

Name
Firmenname
Erasca Inc
Name
Telefon
(858) 465-6511
Name
Adresse
3115 MERRYFIELD ROW, SAN DIEGO
Name
Mitarbeiter
129
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ERAS's Discussions on Twitter

Vergleichen Sie ERAS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ERAS
Erasca Inc
1.48 453.87M 0 -125.04M -122.99M -0.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Erasca Inc Stock (ERAS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-18 Herabstufung Morgan Stanley Overweight → Equal-Weight
2025-03-26 Eingeleitet Raymond James Outperform
2024-11-18 Eingeleitet Jefferies Buy
2024-03-11 Eingeleitet CapitalOne Overweight
2024-01-05 Herabstufung BofA Securities Buy → Neutral
2023-10-11 Eingeleitet H.C. Wainwright Buy
2023-03-30 Eingeleitet Mizuho Buy
2023-02-24 Eingeleitet Goldman Buy
2023-02-03 Hochstufung Morgan Stanley Equal-Weight → Overweight
Alle ansehen

Erasca Inc Aktie (ERAS) Neueste Nachrichten

pulisher
Sep 03, 2025

Erasca Shares Fall After BofA Securities Downgrade - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

Erasca, Candle, Xencor drop as BofA downgrades (ERAS:NASDAQ) - Seeking Alpha

Sep 03, 2025
pulisher
Sep 03, 2025

This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga

Sep 03, 2025
pulisher
Sep 03, 2025

Will Erasca Inc. be affected by tariffsStock Surge & Stock Market Timing Techniques - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Is Erasca Inc. stock heavily shortedWeekly Trade Report & AI Based Buy and Sell Signals - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

BofA Securities Downgrades Erasca to Underperform - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

Why Erasca Inc. is moving todayPrice Action & Growth Focused Investment Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Leading vs lagging indicators on Erasca Inc. performanceExit Point & Verified High Yield Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

BofA Securities downgrades Erasca stock to Underperform on competitive concerns - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

Applying chart zones and confluence areas to Erasca Inc.Earnings Recap Report & Daily Market Momentum Tracking - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Tools to monitor Erasca Inc. recovery probabilityFed Meeting & Comprehensive Market Scan Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What MACD signals say about Erasca Inc.Market Risk Summary & Technical Pattern Based Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 04:17:09 - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Trend analysis for Erasca Inc. this weekEarnings Overview Summary & Weekly High Return Opportunities - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Multi asset correlation models including Erasca Inc.Sell Signal & Weekly Return Optimization Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Regression analysis insights on Erasca Inc. performanceJuly 2025 Drop Watch & Daily Market Momentum Tracking - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using economic indicators to assess Erasca Inc. potentialEarnings Growth Summary & Verified Stock Trade Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What’s next for Erasca Inc. stock price2025 Trade Ideas & Smart Swing Trading Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Erasca Inc. outperform during market rallies2025 Bull vs Bear & Free Accurate Trade Setup Notifications - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Relative strength of Erasca Inc. in sector analysisQuarterly Profit Report & Safe Capital Preservation Plans - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Will Erasca Inc. outperform the marketTake Profit & Weekly High Conviction Trade Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What are Erasca Inc.’s growth leversTrade Volume Report & Free Community Consensus Stock Picks - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Advanced analytics toolkit walkthrough for Erasca Inc.July 2025 Review & Reliable Momentum Entry Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Applying Elliott Wave Theory to Erasca Inc.Earnings Risk Report & AI Enhanced Trading Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How liquid is Erasca Inc. stock2025 Growth vs Value & Fast Moving Stock Watchlists - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Will Erasca Inc. stock recover after earningsWeekly Market Report & Consistent Profit Focused Trading Strategies - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Erasca, Inc. shares rise 4.78% intraday after announcing participation in Morgan Stanley 23rd Annual Global Healthcare Conference. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - The Manila Times

Sep 02, 2025
pulisher
Sep 02, 2025

Precision Oncology Company Erasca to Share RAS/MAPK Cancer Therapy Updates at Morgan Stanley Conference - Stock Titan

Sep 02, 2025
pulisher
Sep 02, 2025

Earnings visualization tools for Erasca Inc.Quarterly Portfolio Summary & High Accuracy Buy Signal Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 05:49:34 - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Does Erasca Inc. show high probability of rebound2025 Top Gainers & Technical Pattern Based Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is this a good reentry point in Erasca Inc.Portfolio Gains Summary & Fast Exit Strategy with Risk Control - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Why is Erasca Inc. stock going upGlobal Markets & Daily Profit Focused Stock Screening - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Erasca Inc. benefiting from interest rate changesJuly 2025 Reactions & Stock Market Timing Techniques - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Erasca Inc. attractive at current valuationJuly 2025 Sector Moves & Weekly Chart Analysis and Guides - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

IPO Launch: Is Erasca Inc. forming a double bottomGap Up & Weekly Sector Rotation Insights - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Will Erasca Inc. benefit from AI trendsJuly 2025 Momentum & Verified Stock Trade Ideas - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Why Erasca Inc. stock attracts strong analyst attentionJuly 2025 Action & Verified Swing Trading Watchlist - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

What the charts say about Erasca Inc. today2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

What indicators show strength in Erasca Inc.July 2025 Trends & Fast Gaining Stock Strategy Reports - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

RSI and MACD Indicate Shift in Erasca Inc. SentimentJuly 2025 Technicals & Daily Growth Stock Investment Tips - beatles.ru

Sep 01, 2025
pulisher
Sep 01, 2025

Wellington Management Group LLP Has $1.17 Million Holdings in Erasca, Inc. $ERAS - Defense World

Sep 01, 2025
pulisher
Aug 31, 2025

Is Erasca Inc. stock ready for a breakoutTrade Volume Summary & Safe Entry Zone Tips - Newser

Aug 31, 2025

Finanzdaten der Erasca Inc-Aktie (ERAS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):